Klebsiella pneumoniae, gram-negativna bakterija iz porodice Enterobacterales, ljudski je patogen koji uzrokuje širok spektar infekcija. Pojava rezistencije na karbapeneme, visoko djelotvornu skupinu antibiotika, u enterobakterija uvjetovala je sve češću upotrebu kolistina kao antibiotika zadnje linije obrane. Upravo je zato pojava sojeva K. pneumoniae rezistentnih na kolistin od velikog kliničkog značaja. Cilj ovog istraživanja bio je otkriti mehanizme rezistencije na kolistin u kliničkih izolata K. pneumoniae prikupljenih u Zagrebu. Metodom mikrodilucije u Mueller-Hinton bujonu ispitana je osjetljivost izolata K. pneumoniae na kolistin i utvrđeno je kako je svih 12 izolata rezistentno na taj antibiotik. Metodama lančane reakcije polimerazo...
Prema Svjetskoj zdravstvenoj organizaciji višestruko rezistentni izolati bakterije Acinetobacter bau...
Klebsiella pneumoniae is a rod-shaped, encapsulated, Gram-negative bacteria associated with multiple...
Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative ba...
Klebsiella pneumoniae, gram-negativna bakterija iz porodice Enterobacterales, ljudski je patogen koj...
Introduction: Recently, a marked increase in the rate of colistin resistant Klebsiella pneumoniae wa...
Klebsiella pneumoniae is a rod-shaped, encapsulated, Gram-negative bacteria associated with multiple...
Gram-negativne bakterije su uzročnici teških bolničkih infekcija, a posebice infekcija rana. Postoji...
Ovo istraživanje provedeno je s ciljem da se utvrde mehanizmi rezistencije na karbapeneme, njihova p...
We report the emergence of colistin resistance in Klebsiella pneumoniae carbapenemase (KPC)-producin...
La diffusion des bactéries multirésistantes aux antibiotiques associée à une diminution du nombre de...
Colistin is a last-resort antibiotic for the treatment of infections caused by multidrug and carbape...
BackgroundOver the last two decades, the prevalence of colistin resistance among the members of Ente...
Colistin is considered as one of a last resort antimicrobial agent against multidrug-resistant Gramn...
The appearance of carbapenem-resistant Klebsiella pneumoniae has increased the use of colistin as a ...
Background: The increasing rate of infections caused by multiple drug resistant gram-negative bacter...
Prema Svjetskoj zdravstvenoj organizaciji višestruko rezistentni izolati bakterije Acinetobacter bau...
Klebsiella pneumoniae is a rod-shaped, encapsulated, Gram-negative bacteria associated with multiple...
Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative ba...
Klebsiella pneumoniae, gram-negativna bakterija iz porodice Enterobacterales, ljudski je patogen koj...
Introduction: Recently, a marked increase in the rate of colistin resistant Klebsiella pneumoniae wa...
Klebsiella pneumoniae is a rod-shaped, encapsulated, Gram-negative bacteria associated with multiple...
Gram-negativne bakterije su uzročnici teških bolničkih infekcija, a posebice infekcija rana. Postoji...
Ovo istraživanje provedeno je s ciljem da se utvrde mehanizmi rezistencije na karbapeneme, njihova p...
We report the emergence of colistin resistance in Klebsiella pneumoniae carbapenemase (KPC)-producin...
La diffusion des bactéries multirésistantes aux antibiotiques associée à une diminution du nombre de...
Colistin is a last-resort antibiotic for the treatment of infections caused by multidrug and carbape...
BackgroundOver the last two decades, the prevalence of colistin resistance among the members of Ente...
Colistin is considered as one of a last resort antimicrobial agent against multidrug-resistant Gramn...
The appearance of carbapenem-resistant Klebsiella pneumoniae has increased the use of colistin as a ...
Background: The increasing rate of infections caused by multiple drug resistant gram-negative bacter...
Prema Svjetskoj zdravstvenoj organizaciji višestruko rezistentni izolati bakterije Acinetobacter bau...
Klebsiella pneumoniae is a rod-shaped, encapsulated, Gram-negative bacteria associated with multiple...
Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative ba...